Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries

  1. Mughal, M.Z.
  2. Baroncelli, G.I.
  3. de Lucas-Collantes, C.
  4. Linglart, A.
  5. Magnolato, A.
  6. Raimann, A.
  7. Santos, F.
  8. Schnabel, D.
  9. Shaw, N.
  10. Nilsson, O.
Revue:
Frontiers in Endocrinology

ISSN: 1664-2392

Année de publication: 2023

Volumen: 13

Type: Révision

DOI: 10.3389/FENDO.2022.1034580 GOOGLE SCHOLAR lock_openAccès ouvert editor